RATIONALE: Androgens can cause the growth of prostate cancer cells. Androgen deprivation therapy may stop the adrenal glands from making androgens. Radiation therapy uses high-energy x-rays to kill tumor cells. PURPOSE: This randomized phase III trial studies androgen-deprivation therapy and radiation therapy in treating patients with prostate cancer.
SponsorsThis trial is sponsored by Radiation Therapy Oncology Group.
Interested in Clinical Trial?
Providers Associated With This Trial
- David R. Clarkson, M.D.Medical OncologistSenior Staff Physician, Medical Oncology Service; Professor of Interdisciplinary Clinical Oncology